LFB, expertise committed to life
Why a Raison d'Être ?
Our Raison d’Être defines the company’s contribution to society. It is the compass that will guide our actions from now on: “LFB, expertise committed to life”.
The Raison d’Être unifies the vision of different businesses within LFB and orients LFB’s operations to continue having a concrete impact on patients and in the world. As one of the first leaders in the French pharmaceutical sector to formally adopt a Raison d’Être, LFB sees the Raison d’Être as an essential prerequisite to becoming a emission-driven company and a necessary first step to continue its work in this direction.
THE RESULT OF COLLECTIVE REFLECTION
LFB consulted all employees worldwide to build together the Raison d’Être. 64% of employees contributed through a digital survey and expressed their vision of LFB and their experience within the company. This high mobilization rate reflects employees who are deeply involved in the LFB’s projects and commitment to LFB’s future. LFB’s partners, including patient and blood donor associations, healthcare professionals, clients, suppliers, banks, and members of the LFB’s Board of Directors, also had a tremendous contribution.
With therapies derived from living organisms, which makes all the difference for patients. Expertise also encompasses the expertise of employees who contribute to making LFB a recognized and essential player thanks to a unique know-how in biopharmaceuticals.
Commitment was, in fact, highlighted as a key value of LFB during the consultation. The sense of commitment is deeply rooted within each employee, as they are all strongly driven by the desire to serve patients.
Drives each and every LFB employee, all of whom are aware that therapies produced by LFB enable the care of patients with serious and often rare diseases, in France and around the world.
LFB takes on a Raison d'Etre
As experts in plasma-derived therapies, LFB is an essential link between donors and patients, thanks to its know-how and its commitment to patients. Invested with a public health mission, a pillar of French health sovereignty, and a recognized international actor, LFB develops, manufactures, and distributes biopharmaceuticals to improve patients’ lives in responsible and sustainable ways.
